We are pleased to announce our newest publication in the International Journal of Cardiology from the desk of Dr. Alexander Samol, Marcus Wiemer, Sven Kaese. Mechanical circulatory support devices are able to generate additional cardiac output or maintain sufficient circulation during high-risk PCI. They prospectively compared the hemodynamic and clinical performance of the new iVAC 2L® device with the Impella 2.  5® device during high-risk PCI. Please follow the link below for the results and the full publication.

Please follow the link below for the poster presentation by Dr. Marcelo Bastos: Effect of Pulsatile Mechanical Circulatory Support on Cardiac Mechanics (PULSE trial)

We are pleased to announce our newest publication in the Cardiovascular Revascularization Medicine from the desk of Prof. Nicolas van Mieghem and Dr. Marcelo Bastos. MCS is increasingly used in the context of high-risk percutaneous coronary intervention (PCI). The effect of the pulsatile iVAC 2L MCS on left ventricular loading conditions and myocardial oxygen consumption (MVO2) is unknown. In this publication, the Erasmus University Medical Centre & Kings College London showcase their clinical experiences with the iVAC 2L device and outline the impact on patients with advanced coronary artery disease at high to prohibitive operative risk in their practice. Please check this link for the full publication.

In this video series, Professor Nicolas van Mieghem will discuss the benefits of iVAC 2L in clinical practice and will share the learnings and key outcomes from the PULSE-Trial, and the effect of next generation pulsatile mechanical circulatory support (MCS). Also this video series has been broken down into 12 shorter clips. Please follow this link.

An expert consensus has been released by the Joint European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute Cardiovascular Care (ACVC) reviewing the pathophysiological context and indications for pVADs in different clinical settings. It also provides guidance regarding the clinical management of patients requiring pVADs. A quick overview is made on the state-of-the art of short-term mechanical circulatory support according to different indications. Additional discussions on the handling of complications, anticoagulation and weaning are also provided. The appendix section describes the theoretical basis for the use of different MCS devices, including how their effects differ. The review has been published on EuroIntervention. Please follow this link for the full publication.

Dr. Ota Hlinomaz, interventional cardiologist at CINRE hospital in Slovak Republic presented during the EuroPCR 2021: Improving outcomes of high-risk protected distal left main intervention by pulsatile circulatory support system. For more information please follow this link.